Analytical Chemistry Clinical Development Licensing Pharmaceuticals 
Drug Discovery World
MARCH 7, 2023
She has over 15 years’ experience in corporate finance and restructurings, mergers and acquisitions, joint ventures and intellectual property licensing. Hu was formerly a consultant at McKinsey & Company where she advised pharmaceutical companies on strategic, operational and organizational issues.
The Pharma Data
NOVEMBER 5, 2020
X4 Pharmaceuticals – Art Taveras was named CSO of Cambridge, Mass.-based Taveras will lead all research and non-clinical development functions supporting the company’s pipeline of investigational therapies. Prior to this, he held a position as a director of Analytical Chemistry in Drug Discovery at GlaxoSmithKline.
Expert insights. Personalized for you.
246 
Let's personalize your content